{"id":"W3091625009","doi":"10.1158/1078-0432.ccr-20-1068","title":"Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Novartis","keywords":"Exemestane; Everolimus; Postmenopausal women; Clinical trial; Breast cancer; Phases of clinical research; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00126646,0.0002415329,0.0008582244,0.0002402769,0.00006182127,0.00001909843,0.0001664204,0.0001626347,0.0002044908],"category_scores_gemma":[0.0002365718,0.0001831579,0.00003247018,0.001362579,0.0006971323,0.0003196082,0.00009174522,0.001047794,0.000002412154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006232455,"about_ca_system_score_gemma":0.001136831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008234541,"about_ca_topic_score_gemma":0.000877658,"domain_scores_codex":[0.9963327,0.0004095797,0.0008477235,0.0007309538,0.001037917,0.0006411101],"domain_scores_gemma":[0.997913,0.0005532812,0.0002223209,0.0003210034,0.0005539389,0.0004364815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6187199,0.002550824,0.05522748,0.0002825652,0.00009390579,0.000121661,0.001593887,0.0002136477,0.004231393,0.0000421169,0.00001847068,0.3169042],"study_design_scores_gemma":[0.4776755,0.04208178,0.4738113,0.001354012,0.00004868837,0.00002846809,0.001711619,0.0009507267,0.0007245824,0.0003201827,0.0009080495,0.0003850783],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874287,0.0008096924,0.00005044912,0.009401512,0.0000712596,0.002059786,0.0000715425,0.00003428293,0.00007278845],"genre_scores_gemma":[0.9968138,0.001185193,0.000375098,0.0004903718,0.0002376695,0.0007513501,0.00001960341,0.00006030138,0.00006654986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4185838,"threshold_uncertainty_score":0.746896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1001927065520941,"score_gpt":0.4821527075478383,"score_spread":0.3819600009957443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}